Plate Nº 50 · recorded September 29, 2026
Health & Medicine ResearchReported finding
Short Steroid Courses Raise Pneumonia and Heart Failure Risk in Diabetes
A study of 36,048 adults with type 2 diabetes found that short oral steroid courses doubled pneumonia risk and raised heart failure risk by 87% in the first month.
By Marcus Bennett3 min read645 words
In brief
- Short oral steroid courses in adults with type 2 diabetes were linked to double the pneumonia risk, 87% higher heart failure risk and 71% higher gastrointestinal bleeding risk in the first month.
- Risks lingered after treatment: one to three months later, fracture risk was 1.42 times baseline and stomach bleeding risk remained 26% above normal.
- The self-controlled study of 36,048 adults used 15 years of data from Taiwan's National Health Insurance Research Database and was published in JAMA Network Open.
Adults with type 2 diabetes who take even short courses of oral steroids face a sharply higher risk of pneumonia, heart failure and stomach bleeding in the weeks that follow, according to a new study published in JAMA Network Open.
The researchers analyzed health records from 36,048 adults and found that the risks did not fade quickly. Some lingered for as long as three months after treatment began.
What the study found
The team, led by Tsung-Chieh Yao, drew on 15 years of data from Taiwan's National Health Insurance Research Database. They identified adults with type 2 diabetes who had received a short course of oral steroids, then used a method called a self-controlled case series. In this design, each patient serves as their own control: the researchers compared each person's risk of a medical emergency in the weeks after taking steroids against their own baseline risk when they were not taking the medication.
During the first month after starting a steroid burst, patients faced:
- Double the risk of pneumonia compared with their baseline
- An 87% higher risk of heart failure
- A 71% higher risk of gastrointestinal bleeding (bleeding in the stomach or intestines)
The risks declined over time but did not disappear. Between one and three months after starting treatment, the risk of bone fractures remained 1.42 times higher than baseline — a 42% increase — and the risk of stomach bleeding stayed 26% above normal.
Why steroids matter for people with diabetes
Corticosteroids are synthetic versions of cortisol, the hormone the adrenal glands release as part of the body's stress response. Doctors often prescribe short, high-dose courses of these drugs to treat allergy and asthma flare-ups, because they rapidly reduce inflammation.
For people with diabetes, the drugs carry a known complication: they can disrupt glucose homeostasis — the body's system for keeping blood sugar within a narrow, healthy range. Corticosteroid bursts raise blood glucose by making the body more resistant to insulin and by reducing how much insulin the pancreas produces and releases.
The timing of these effects varies by drug. With prednisolone, blood sugar can climb within a few hours of a dose and then fall back down. Other corticosteroids, such as dexamethasone, can keep blood sugar elevated for much longer.
Medical guidelines already advise doctors to watch for blood sugar spikes when prescribing oral steroid bursts to people with diabetes. What researchers did not know was whether short courses pose serious risks beyond raised blood sugar. Adults with type 2 diabetes are already vulnerable to infections, cardiovascular problems and fractures, so quantifying how much extra risk a steroid course adds to that existing burden matters for everyday prescribing decisions.
What the findings mean — and what they don't
The study does not suggest that doctors should stop prescribing oral corticosteroids. These are essential medications, and for conditions like severe asthma attacks they can be lifesaving. The researchers instead argue that the numbers warrant carefully weighing risks against benefits when prescribing steroid bursts to this high-risk population.
The findings come with caveats. The data come from a single country's insurance database, and the results may not transfer directly to other populations with different health systems, lifestyles or genetic backgrounds. The study was observational in nature — it identifies associations between steroid bursts and adverse events but cannot by itself prove that the steroids caused every emergency counted.
The researchers call for further studies in wider populations to build robust, evidence-based guidelines that clinicians can follow when prescribing corticosteroids to people with diabetes.
For now, the message for patients and doctors is one of awareness rather than alarm. A short course of steroids remains a valuable tool — but for people with type 2 diabetes, the weeks following treatment appear to carry a measurably higher risk of serious complications, and that window deserves closer attention.
via Medical Xpress (Source)
More from Marcus Bennett
Nearby plates
- Diet and Exercise Reverse Early-Onset Type 2 Diabetes in Half of Cases
- Amylin Drug Petrelintide Delivers Over 10% Weight Loss
- Early Statin Use After Diabetes Diagnosis Linked to Lower Dementia Risk
- Triple-Action Drug Retatrutide Delivers Major Weight Loss in Type 2 Diabetes
- Screening Children for Type 1 Diabetes Is Feasible, 8-Country Study Finds